Vortioxetine for depression in adults-Reference-Cited by-同舟云学术

Vortioxetine for depression in adults

Published:2017-07-05 Issue:7 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Koesters Markus¹,Ostuzzi Giovanni²,Guaiana Giuseppe³,Breilmann Johanna¹,Barbui Corrado⁴

Affiliation:

1. Ulm University; Department of Psychiatry II; Ludwig-Heilmeyer-Str. 2 Guenzburg Germany D-89312

2. University of Verona; Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry; Policlinico "GB Rossi" Piazzale L.A. Scuro, 10 Verona Italy 37134

3. Western University; Department of Psychiatry; Saint Thomas Elgin General Hospital 189 Elm Street St Thomas ON Canada N5R 5C4

4. University of Verona; Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry; Verona Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011520.pub2/epdf/full

Reference125 articles.

1. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder;Alvarez;International Journal of Neuropsychopharmacology,2012

2. NCT00839423 Randomised placebo-controlled venlafaxine-referenced study of efficacy and safety of 5 and 10 mg of vortioxetine (Lu AA21004) in acute treatment of major depressive disorder in adults clinicaltrials.gov/ct2/show/NCT00839423

3. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in MDD treatment;Baldwin;European Neuropsychopharmacology,2011

4. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD);Baldwin;European Neuropsychopharmacology,2012

5. NCT00635219 Randomised placebo-controlled duloxetine-referenced efficacy and safety study of 2.5, 5 and 10 mg of vortioxetine (Lu AA21004) in acute treatment of major depressive disorder clinicaltrials.gov/ct2/show/NCT00635219

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine for depression in adults: A systematic review and dose–response meta‐analysis of randomized controlled trials;Psychiatry and Clinical Neurosciences;2024-07-03

2. Depression and anxiety in multiple sclerosis. Review of a fatal combination;Journal of Neural Transmission;2024-06-13

3. Neuroproteomics: Unveiling the Molecular Insights of Psychiatric Disorders with a Focus on Anxiety Disorder and Depression;Advances in Experimental Medicine and Biology;2024

4. Use of sertraline and agomelatine in hemodialysis patients: A case series report;Acta Biochimica Polonica;2023-12-03

5. Repercusión de vortioxetina sobre la función sexual frente a otros antidepresivos;Medicina de Familia. SEMERGEN;2023-10